FNDC3B enhances adipose tissue function by increasing adipogenesis and improving cellular energy efficiency by promoting oxidative phosphorylation and thermogenesis, with PRDM16 and TWIST1 playing similar roles in modifying CAD risk (Figure 1). Here, FNDC3B is linked to coronary artery disorder.